|Articles|October 14, 2020
- Pharmaceutical Executive-10-01-2020
- Volume 40
- Issue 10
Pharmaceutical Executive, October 2020 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive October 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 6 years ago
The SPAC Makes a Comeback!almost 6 years ago
Leadership and Industry Imagealmost 6 years ago
Assets in Anxious Times: Patient Hubs Demonstrate Value During COVID-19almost 6 years ago
The Interplay Between COVID-19 Pandemic and NCD Epidemicalmost 6 years ago
FDA Struggles to Retain Credibilityalmost 6 years ago
Critical Connection: Patient Services and Product Launchalmost 6 years ago
Mastering the Transition From Academia to Industryalmost 6 years ago
Smoothing Access Pathalmost 6 years ago
The COVID Boost to AI in Global Healthalmost 6 years ago
Speed and SensitivityAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
AI at the FDA: Efficiency, Oversight, and Open Questions
2
Pharmaceutical Executive Daily: 2026 Emerging Pharma Leaders Award Winners Announced
3
FDA Grants Accelerated Approval to Zenbexus Plus Daratumumab and Hyaluronidase-fihj and Dexamethasone for Multiple Myeloma
4
The Impact from Overlaps Between 340B and the IRA
5